Longwood Fund II, L.P., 10% Owner at Flex Pharma, Inc. (FLKS), bought 312,500 shares at $16.00 ($5.0M) on 2015-02-03, disclosed to the SEC on 2015-02-13.
Open-market purchase of $5.0M FLKS by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| Filing → |